West Pharmaceutical Services, I vs Intuitive Surgical, Inc.
A head-to-head of West Pharmaceutical Services, I (WST) and Intuitive Surgical, Inc. (ISRG) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | WST | ISRG |
|---|---|---|
| Market Cap | $25.31B | $122.33B |
| P/E (TTM) | 47.79 | 41.87 |
| Forward P/E | 34.01 | 28.83 |
| P/S | 6.48 | 14.66 |
| P/B | 8.67 | 6.96 |
| EV/EBITDA | 24.06 | 38.80 |
| Dividend Yield | 0.24% | — |
| Profit Margin | 16.85% | 28.15% |
| Gross Margin | 35.89% | 66.00% |
| Operating Margin | 20.09% | 29.27% |
| Revenue Growth (YoY) | +21.01% | +22.96% |
| FCF Yield | 2.19% | 1.83% |
| Debt / Equity | 7.50 | — |
| Current Ratio | 2.71 | 4.61 |
Which is better: West Pharmaceutical Services, I or Intuitive Surgical, Inc.?
- ✓Larger by market cap: Intuitive Surgical, Inc.
- ✓Cheaper valuation (lower P/E): Intuitive Surgical, Inc.
- ✓More profitable (net margin): Intuitive Surgical, Inc.
- ✓Faster revenue growth: Intuitive Surgical, Inc.
- ✓Higher free-cash-flow yield: West Pharmaceutical Services, I
Across 11 available metrics, Intuitive Surgical, Inc. leads 8–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.